Author:
Bielinski S J,St Sauver J L,Olson J E,Wieland M L,Vitek C R,Bell E J,Mc Gree M E,Jacobson D J,McCormick J B,Takahashi P Y,Black J L,Caraballo P J,Sharp R R,Beebe T J,Weinshilboum R M,Wang L,Roger V L
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference20 articles.
1. U.S. Food and Drug Administration Table of Pharmacogenomic Biomarkers in Drug Labels. USDA: Silver Spring, MD. Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.
2. Obama B (2015). Remarks by the President on Precision Medicine. Office of the Press Secretary. January 30, 2015. Available at: https://www.whitehouse.gov/the-press-office/2015/01/30/remarks-president-precision-medicine (accessed 10/2016).
3. Meckley LM, Neumann PJ . Personalized medicine: factors influencing reimbursement. Health Policy 2010; 94: 91–100.
4. Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc 2014; 89: 25–33.
5. Rasmussen-Torvik LJ, Stallings SC, Gordon AS, Almoguera B, Basford MA, Bielinski SJ et al. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther 2014; 96: 482–489.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献